dc.contributor.author |
Anke Kijjoa |
|
dc.contributor.author |
Nair Campos |
|
dc.contributor.author |
Werner Herz |
|
dc.contributor.author |
Madalena Pinto |
|
dc.contributor.author |
Maria são josé Nascimento |
|
dc.contributor.author |
เอนก กิจเจา |
|
dc.contributor.other |
Institute of Marine Science |
|
dc.date.accessioned |
2019-03-25T09:14:45Z |
|
dc.date.available |
2019-03-25T09:14:45Z |
|
dc.date.issued |
2007 |
|
dc.identifier.uri |
http://dspace.lib.buu.ac.th/xmlui/handle/1234567890/2343 |
|
dc.description.abstract |
The pyridoacridine alkaloids kuanoniamines A and C were isolated together with 24 α-methylcholestanol, p-hydroxybenzaldehyde, p-hydroxybenzoic acid, phenylacetic acid and 3-formylindole from the ethyl acetate extract of the marine sponge Oceanapia sagittaria (Sollas), collected from the Gulf of Thailand. Kuanoniamines A and C were evaluated for their effect on the growth of five human tumour and a non-tumour cell lines, as well as on the proliferation of human lymphocytes. Kuanoniamine A was found to be a potent growth inhibitor of all the tumour and a non-tumour cell lines while kuanoniamine C was less potent but showed high selectivity toward the estrogen dependent (ER+) breast cancer cell line. Kuanoniamine A has shown to be a more potent inhibitor of DNA synthesis than kuanoniamine C. Kuanoniamine A was also found to cause an extensive reduction of the MCF-7 cells in G2/M phase as well as an increase in the apoptotic cells. |
en |
dc.language.iso |
eng |
th_TH |
dc.subject |
anti-proliferation of human lymphocytes |
th_TH |
dc.subject |
anticancer activity |
th_TH |
dc.subject |
Apoptosis |
th_TH |
dc.subject |
cell cycle progression |
th_TH |
dc.subject |
Oceanapia sagittaria |
th_TH |
dc.title |
Unbound MEDLINE Anticancer activity evaluation of kuanoniamines A and C isolated from the marine sponge Oceanapia sagittaria, collected from the Gulf of Thailand |
en |
dc.type |
บทความวารสาร |
th_TH |
dc.issue |
2 |
|
dc.volume |
5 |
|
dc.year |
2007 |
|
dc.journal |
Mar. Drugs |
|
dc.page |
6-22. |
|